About Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn engaged in the activities pertaining to manufacturing of Bulk Drugs.
Founded
1981
CEO
Dinesh S Patel
Employees
372
HQ
Mumbai, India
Finished Products
1Sales
₹320.53Cr2Raw Material for SAS
₹0.07Cr3Other Operating Revenue
₹0.01Cr4scrap
₹0.01CrRaw Materials
1Raw Material
₹49.20Cr2Laboratory Chemicals
₹1.62Cr3Packing Material
₹0.62CrAbout Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn engaged in the activities pertaining to manufacturing of Bulk Drugs.
Founded:1981
CEO:Dinesh S Patel
Employees:372
HQ:Mumbai, India
Finished Products
1Sales
₹320.53Cr2Raw Material for SAS
₹0.07Cr3Other Operating Revenue
₹0.01Cr4scrap
₹0.01CrRaw Materials
1Raw Material
₹49.20Cr2Laboratory Chemicals
₹1.62Cr3Packing Material
₹0.62CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹479
52W Low
₹225
Volume1.72M
Avg VolumeN/A
Beta1.67
Dividend Yield0.14%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
110.32x
Valuation
P/B Ratio
5.17x
Valuation
EPS
₹3.74
Valuation
Dividend Yield
0.14%
Valuation
ROE
16.22%
Profitability
ROCE
14.47%
Profitability
Revenue by Segment
Contribution & growth by business line
Bulk Drugs for its own & Job WorkRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
100.0%
International
0.0%
India100.0%
Strategic Relations
Collaborations, joint ventures & subsidiaries
Y
Yuhan Corporation
South Korea
33.19% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.56x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.